Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta

Published online by Cambridge University Press:  20 June 2025

Aims: Withania somnifera widely known as “Ashwagandha”, is a key treatment herb in the Indian system of medicine that has been used for thousands of years. It has anti-inflammatory, neuroprotective, adaptogenic, and immunomodulatory activities.

Methods: From inception through September 8, 2024, we searched for randomized clinical trials investigating the effect of ashwagandha on adults. The literature search involved PubMed, Web of Science, Scopus, and Cochrane databases. We included all randomized controlled trials that met the following criteria: (1) conducted on adult participants with stress and/or anxiety; (2) investigated the effects of ashwagandha supplementation compared with a placebo or other active treatments; (3) reported outcomes using validated measures of stress and anxiety. Two reviewers independently extracted the relevant data from the included studies using an Excel sheet. The analysis was carried out using R (version 4.4.1) and the metafor package (version 4.6.0).

Results: A total of 15 studies were included with a combined sample size of 873 patients. We found that ashwagandha supplementation significantly reduced anxiety compared with placebo according to the Hamilton Anxiety Rating Scale (HAM-A) before μ =−1.55 (95% CI: −2.45 to −0.65, p=0.0007) and at 8 weeks of treatment μ=−3.52 (95% CI: −6.00 to −1.04, p=0.0053). It has also showed a signifacnt effect in reducing both stress (Perceived Stress Scale (PSS) μ=−4.88 (95% CI: −7.84 to −1.91, p=0.0013)) and cortisol levels μ=−2.3626 (95% CI: −3.2622 to −1.4629), p<0.0001) at 8 weeks of treatment. On the other hand, no improvement in the quality of life has been observed μ =−1.7618 (95% CI: −5.6118 to 2.0881, p=0.3698).

Conclusion: Ashwagandha supplementation is safe and effective in reducing stress and anxiety in adult patients. In our study, it resulted in a statistically significant reduction of cortisol levels, PSS scale, and HAM-A scale. However, it showed no statistically significant improvement in the quality of life of participants receiving it.

Abstracts were reviewed by the RCPsych Academic Faculty rather than by the standard BJPsych Open peer review process and should not be quoted as peer-reviewed by BJPsych Open in any subsequent publication.

Official websites use .gov

A
.gov website belongs to an official
government organization in the United States.

Secure .gov websites use HTTPS

A lock (

Lock

Locked padlock icon

) or https:// means you’ve safely
connected to the .gov website. Share sensitive
information only on official, secure websites.

Logged in as:

Abstracts were reviewed by the RCPsych Academic Faculty rather than by the standard BJPsych Open peer review process and should not be quoted as peer-reviewed by BJPsych Open in any subsequent publication.

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.